|
1. Brackbill Y, Berendes HW. Dangers of diethylstilbestrol: review of a 1953 paper. Lancet 1978;2:520.
2. Dieckmann WJ, Davis ME, Rynkiewicz LM, Pottinger RE. Does the administration of diethylstilbestrol during pregnancy have therapeutic value? Am J Obstet Gynecol 1953;66(5):1062-81.
3. Dodds EC, Goldberg L, Larson W, Robinson R. Estrogenic activity of certain synthetic compounds. Nature 1938;141:247.
4. Fergeson JH. Effect of stilbestrol on pregnancy compared to the effect of a placebo. Am J Obstet Gynecol 1953;65:592-601.
5. Guisti RM, Iwamoto K, Hatch EE. Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med 1995;122:778-88.
6. Heinonen OP. Diethylstilbestrol in pregnancy: frequency of exposure and usage patterns. Cancer 1973;31:573-7.
7. Johnston GA Jr. Health risks and effects of prenatal exposure to diethylstilbestrol. J Fam Pract 1983 Jan;16(1):51-4.
8. Kinlen LJ, Badaracco MA, Moffett J, Vessey MP. A survey of the use of estrogens during pregnancy in the United Kingdom and of the genito-urinary cancer mortality and incidence rates in young people in England and Wales. J Obstet Gynaecol Br Commonwlth 1974;81:849-55.
9. Noller KL, Fisch CR. Diethylstilbestrol usage: its interesting past, important present, and questionable future. Med Clin North Am 1974;58(4):739-810.
10. Reid DD. The use of hormones in the management of pregnancy in diabetics: report to the Medical Research Council by their Conference on Diabetes and Pregnancy. Lancet 1955;6895:833-6.
11. Sharp GB, Cole P, Anderson D, Herbst AL. Clear cell adenocarcinoma of the lower genital tract. Correlation of mother's recall of diethylstilbestrol history with obstetrical records. Cancer 1990;66(10):2215-20.
12. Smith OW. Diethylstilbestrol in the prevention and treatment of complications of pregnancy. Am J Obstet Gynecol 1948;56:821-34.
13. Smith OW, Smith G, Van S. The influence of diethylstilbestrol on the progress and outcome of pregnancy based on a comparison of treated with untreated primigravidas. Am J Obstet Gynecol 1949;58:994.
14. Swyer GIM, Law RG. An evaluation of the prophylactic ante-natal use of stilbestrol: preliminary report. J Endocrinol 1954;10:6.
15. Tilley BC, Barnes AB, Bergstralh E, Labarthe D, Noller KL, Colton T. A comparison of pregnancy history recall and medical records: Implications or retrospective studies. Amer J Epidemiol 1985;121(2):269-81.
16. Trimble EL. Update on diethylstilbestrol. Obstet Gynecol Surv 2001;56(4):187-9.
17. Beral V, Colwell L. Randomized trial of high doses of stilbestrol and ethisterone in pregnancy: long-term follow-up of mothers. Brit Med J 1980;281:1098-1101.
18. Bibbo M, Haenszel WM, Wied GL, Hubby M, Herbst AL. A twenty-five year follow-up study of women exposed to diethylstilbestrol during pregnancy. N Engl J Med 1978;298(14):763-7.
19. Brian DD, Tilley BC, Labarthe DR, O'Fallon WM, Noller KL, Kurland LT. Breast cancer in DES-exposed mothers - absence of association. Mayo Clin Proc 1980;55:89-93.
20. Braun MM, Ahlbom A, Floderus B, Brinton LA, Hoover RN. Effect of twinship on incidence of cancer of the testis, breast, and other sites [Sweden]. Cancer Causes Control 1995;6:519-24.
21. Calle EE, Mervis CA, Thun MJ, Rodriguez C, Wingo PA, Health CW. Diethylstilbestrol and risk of fatal breast cancer in a prospective cohort of US women. Am J Epidemiol 1996;144(7):645-51.
22. Cohen I, Altaras M, Jaffe R, Markov S, Corduba M, Ben Aderet N. Ovarian cancer in women given diethylstilbestrol in pregnancy: two case reports. J Pathol 1987;152(2):95-7.
23. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-27.
24. Colton T, Greenberg ER, Noller K, Resseguie L, Van Bennekom C, Heeren T, et al. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy: Further follow-up. JAMA 1993;269:2096-100.
25. Greenberg ER, Barnes AB, Resseguie L, Barrett JA, Burnside S, Lanza LL, et al. Breast cancer in mothers given diethylstilbestrol in pregnancy. N Eng J Med 1984;311(22):1393-8.
26. Hadjimichael OC, Meigs JW, Falcier FW, Thompson WD, Flannery JT. Cancer risk among women exposed to exogenous estrogens during pregnancy. J Natl Cancer Inst 1984;73(4):831-4.
27. Herbst AL, Poskanzer DC, Robboy SJ, Friedlander l, Scully RE. A prospective comparison of exposed female offspring with unexposed controls. N Engl J Med 1975;292(7):334-9.
28. Hoover R, Gray LA Sr, Fraumeni JD Jr. Stilbestrol (diethylstilbestrol) and the risk of ovarian cancer. Lancet 1977;2(8037):533-4.
29. Hubby MM, Haenszel WM, Herbst AL. Effects on mother following exposure to diethylstilbestrol during pregnancy. In: Herbst AL, Bern HA, editors. Developmental effects of diethylstilbestrol (DES) in pregnancy. New York: Thieme-Stratton, Inc.; 1981. Chapter 9.
30. Kelsey JL, Berkowitz GS: Breast cancer epidemiology [review]. Cancer Res 1988;48(20):5615-23.
31. Meara J, Vessey M, Fairweather DV. A randomized double-blind controlled trial of the value of diethylstilbestrol therapy in pregnancy: 35 years follow-up of mothers and their offspring. Brit J Obstet Gynecol 1989;96(5):620-2.
32. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997;71:800-9.
33. Titus-Ernstoff L, Hatch EE, Hoover RN, Palmer J, Greenberg ER, Ricker W, et al. Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer 2001;84:126-33.
34. Vessey MP, Fairweather DVI, Norman-Smith B, Buckley J. A randomized double blind controlled trial of the value of stilbestrol therapy in pregnancy: Long-term follow-up of mothers and their offspring. Brit J Obstet Gynecol 1983;90:1007-17.
35. Wingard DL, Turiel J. Long-term effects of exposure to diethylstilbestrol. West J Med 1988;149(5):551-4.
36. Adam E, Decker DG, Herbst AL, Noller KL, Tilley BC, Townsend DE. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones. Cancer Res 1977 April;37(4):1249-51.
37. Antonioli DA, Burke L, Friedman EA. Natural history of diethylstilbestrol-associated genital tract lesions: cervical extopy and cervicovaginal hood. Am J Obstet Gynecol 1980;137(7):847-53.
38. Assies J. Hyperprolactinaemia in diethylstilbestrol-exposed women [letter]. Lancet 1991;337:983.
39. Barnes AB. Menstrual history and fecundity of women exposed and unexposed in utero to diethylstilbestrol. J Reprod Med 1984;29:651-5.
40. Barnes AB, Fish C, Gundersen JH, et al. Vaginal and cervical changes in DES-exposed women. Resident Staff Phys 1981;12:112-3.
41. Ben-Baruch G, Menczer J, Mashiach S, Serr DM. Uterine anomalies in diethylstilbestrol-exposed women with fertility disorders. Acta Obstet Gynecol Scand 1981;60(4):395-7.
42. Bibbo M, Gill WB, Azizi F, Blough R, Fang VS, Rosenfield RL, et al. Follow-up study of male and female offspring of DES-exposed mothers. Obstet Gynecol 1977;49(1):1-7.
43. Burke L, Antonioli D, Friedman EA. Evolution of diethylstilbestrol-associated genital tract lesions. Obstet Gynecol 1981;57(1):79-84.
44. DeCherney AH, Cholst I, Naftolin F. Structure and function of the fallopian tubes following exposure to diethylstilbestrol (DES) during gestation. Fertil Steril 1981;36(6):741-5.
45. Haney AF, Hammond CB, Soules MR, Creasman WT. Diethylstilbestrol-induced upper genital tract abnormalities. Fertil Steril 1979;31:142-6.
46. Herbst AL, Hubby MM, Anderson D. Neoplastic changes in the human female genital tract following intrauterine exposure to diethylstilbestrol. Progr Cancer Res Therapy 1984;31:389-99.
47. Herbst AL, Poskanzer DC, Robboy SJ, Friedlander L, Scully RE. Prenatal exposure to stilbestrol: a prospective comparison of exposed female offspring with unexposed controls. N Engl J Med 1975;292:334-9.
48. Hornsby P, Wilcox A. Onset of menopause in women exposed to diethylstilbestrol in utero [abstract]. Am J Epidemiol 1991;134(7):770.
49. Jefferies JA, Robboy SJ, O'Brien PC, Bergstralh EJ, Labarthe DR, Barnes AB, et al. Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project. Am J Obstet Gynecol 1984;148:59-66.
50. Kaufman RH, Adam E. Genital tract anomalies associated with in utero exposure to diethylstilbestrol. Isr J Med 1978;14(3):353-62.
51. Kaufman RH, Binder GL, Gray PM, Adam E. Upper genital tract changes associated with exposure in utero to diethylstilbestrol. Am J Obstet Gynecol 1977;128(1):51-9.
52. Kaufman RH, Adam E, Binder GL, Gerthoffer E. Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol. Am J Obstet Gynecol 1980;137(3):299-308.
53. Kaufman RH, Adam E, Grey MP, Gerthoffer E. Urinary tract changes associated with exposure in utero to diethylstilbestrol. Obstet Gynecol 1980;56(3):330-2.
54. Kaufman RH. Structural changes of the genital tract associated with in utero exposure to diethylstilbestrol. Obstet Gynecol Annu 1982;11:187-202.
55. Labarthe D, Adam E, Noller KL, O'Brient PC, Robboy SJ, Tilley BC, et al. Design and preliminary observations in the National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol 1978;51:453.
56. Noller KL, Townsend DE, Kaufman RH, Barnes AB, Robboy SJ, Fish CR, et al. Maturation of vaginal and cervical epithelium in women exposed in utero to diethylstilbestrol (DESAD Project). Am J Obstet Gynecol 1983;146(3):279-85.
57. Noller KL, Townsend D, Kaufman RH. Genital findings colposcopic evaluation, and current management of the diethylstilbestrol-exposed female. In: Herbst AL, Bern HA, editors. Developmental effects of diethylstilbestrol (DES) in pregnancy. New York: Thieme-Stratton, Inc.; 1981. Chapter 7.
58. O'Brien PC, Noller KL, Robboy SJ, Barnes AB, Kaufman RH, Tilley BC, et al. Vaginal epithelial changes in young women enrolled in the National Cooperative Adenosis (DES) Project. Obstet Gynecol 1979;53:300-8.
59. Peress MR, Tsai CC, Mathur RS, Williamson HO. Hirsutism and menstrual patterns in women exposed to diethylstilbestrol in utero. Am J Obstet Gynecol 1982;144(2):135-40.
60. Rennell CL. T-shape uterus in diethylstilbestrol (DES) exposure. AJR Am J Roentgenol 1979;132(6):979.
61. Robboy SJ, Noller KL, O'Brien P, Kaufman RH, Townsend D, Barnes AB, et al. Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women: experience of the National Collaborative Diethylstilbestrol Adenosis Project. JAMA 1984;252:2979-83.
62. Robboy SJ, Kaufman RH, Prat J, Welch WR, Gaffey T, Scully RE, et al. Pathologic findings in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol 1979;53:309-17.
63. Robboy SJ, Taguchi O, Cunha GR. Normal development of the human female reproductive tract and alterations resulting from experimental exposure to diethylstilbestrol. Hum Pathol 1982;13(3):190-8.
64. Schmidt G, Fowler WC Jr. Cervical stenosis following minor gynecologic procedures on DES-exposed women. Obstet Gynecol 1980;56(3):333-5.
65. Scully RE, Welch WR. Pathology of the female genital tract after prenatal exposure to diethylstilbestrol. In: Herbst AL, Burn HA, editors. Developmental effects of diethylstilbestrol (DES) in pregnancy. New York: Thieme-Stratton, Inc.; 1981. Chapter 3.
66. Singer MS, Hochman M. Incompetent cervix in a hormone-exposed offspring. Obstet Gynecol 1978;51:625-6.
67. Stillman RJ. In utero exposure to diethylstilbestrol: adverse effects on the reproductive performance of male and female offspring. Am J Obstet Gynecol 1982;142(7):905-21.
68. Vessey MP, Fairweather DVI, Norman-Smith B, Buckley J. A randomized double blind controlled trial of the value of stilbestrol therapy in pregnancy: long-term follow-up of mothers and their offspring. Brit J Obstet Gynecol 1983;90:1007-17.
69. Viscomi GN, Gonzalez R, Taylor KJ. Ultrasound detection of uterine abnormalities after diethylstilbestrol (DES) exposure. Radiology 1980;136(3):733-5.
70. Wu CH, Mangan CE, Burtnett MM, Mikhail G. Plasma hormones in DES-exposed females. Obstet Gynecol 1980;55(2):157-62.
71. Zerner J, Fu YS, Taxiarchis LN, Reagan JW, Richart RM. A clinicopathologic study of vagina and cervix in DES-exposed progeny. Diagn Gynecol Obstet 1980;2(4):245-56.
72. Adams DM, Druzin ML, Cederaquist LL. Intrapartum uterine rupture. Obstet Gynecol 1989;77(3 pt 2):471-3.
73. Alper MM, Oskowitz SP, Berger MJ, Thompson IE, Whitmyer J, Powers RD. Pregnancy after gamete intrafallopian transfer in a women with primary infertility and in utero exposure to diethylstilbestrol [case report]. J Reprod Med 1988;33(5):489-91.
74. Balasch J, Coll O, Jove I, Moreno V, Mulet J, Vanrell JA. Diethylstilbestrol-induced Müllerian abnormalities, septate uterus, genital tuberculosis and twin pregnancy with term delivery after in vitro fertilization. Human Reprod 1991;6(5):690-3.
75. Barnes AB, Colton T, Gundersen J, Noller KL, Tilley BC, Strama T, et al. Fertility and outcome of pregnancy in women exposed in utero to diethylstilbestrol. N Eng J Med 1980;302(11):609-13.
76. Ben-Baruch G, Menczer J, Mashiach S, Serr DM. Uterine anomalies in diethylstilbestrol-exposed women with fertility disorders. Acta Obstet Gynecol Scand 1981;60(4):395-7.
77. Berger MJ, Goldstein DP. Impaired reproductive performance in DES-exposed women. Obstet Gynecol 1980;55(1):25-7.
78. Bibbo M, Gill WB, Azizi F, Blough R, Fang VS, Rosenfield RL, et al. Follow-up study of male and female offspring of DES-exposed mothers. Obstet Gynecol 1977;49(1):1-8.
79. Claman P, Berger MJ. Phenotypic differences in upper genital tract abnormalities and reproductive history in dizygotic twins exposed to diethylstilbestrol in utero [case report]. J Reprod Med 1990;35(4):431-3.
80. Cousins L, Karp W, Lacey C, Lucas WE. Reproductive outcome of women exposed to diethylstilbestrol in utero. Obstet Gynecol 1980;56(1):70-6.
81. DeCherney AH, Cholst I, Naftolin F. Structure and function of the fallopian tubes following exposure to diethylstilbestrol (DES) during gestation. Fertil Steril 1981;36(6):741-5.
82. Edelman DA, Badrawi HH. Contraception for women exposed in utero to diethylstilbestrol. Adv Contracept 1988;4(3):241-6.
83. Goldberg J, Falcone T. Effect of diethylstilbestrol on reproductive function. Fertil Steril 1999;72:1-7.
84. Goldstein DP. Incompetent cervix in offspring exposed to diethylstilbestrol in utero. Obstet Gynecol 1978;52(Suppl):S73-S5.
85. Halling A, Forsberg JG. Ovarian failure after exposure to diethylstilbestrol in neonatal life. Biol Reprod 1990;43(3):472-7.
86. Haney AF, Hammond MG. Infertility in women exposed to diethylstilbestrol in utero. J Reprod Med 1983;28(12):851-6.
87. Herbst AL, Hubby MM, Blough RR, Azizi F. A comparison of pregnancy experience in DES-exposed and DES-unexposed daughters. J Reprod Med 1980;24(2):62-9.
88. Herbst AL, Poskanzer DC, Robboy SJ, Friedlander L, Scully RE. Prenatal exposure to stilbestrol: a prospective comparison of exposed female offspring with unexposed controls. N Engl J Med 1975;292:334-9.
89. Herbst AL, Hubby MM, Azizi F, Makii MM. Reproductive and gynecologic surgical experience in diethylstilbestrol-exposed daughters. Am J Obstet Gynecol 1981;141:1019-28.
90. Hricak H, Chang YC, Cann CE, Parer JT. Cervical incompetence: preliminary evaluation with MR imaging. Radiology 1990;173(3 pt 1):821-6.
91. Karande VC, Lester RG, Muasher SJ, Jones DL, Acosta AA, Jones HW Jr. Are implantation and pregnancy outcome impaired in diethylstilbestrol-exposed women after in utero fertilization and embryo transfer? Fert Steril 1990;54(2):287-91.
92. Kaufman RH, Adam E, Hatch EE, Noller K, Herbst AL, Palmer JR, et al. Pregnancy outcomes in diethylstilbestrol-exposed offspring: Continued follow-up. Obstet Gynecol 2000;96:483-9.
93. Kaufman RH, Noller K, Adam E, Irwin J, Gray M, Jefferies JA, et al. Upper genital tract abnormalities in pregnancy outcome in diethylstilbestrol-exposed progeny. Am J Obstet Gynecol 1984;148:973.
94. Kaufman RH, Binder GL, Gray PM Jr, Adam E. Upper genital tract changes associated with in utero exposure to diethylstilbestrol. Am J Obstet Gynecol 1977;128:51-9.
95. Lazar R, Guegeuen S, Dreyfus J, Renaud R, Pontonnier G, Papiernik E, et al. Multicentered controlled trial of cervical cerclage of women at moderate risk of preterm delivery. Br J Obstet Gynaecol 1984;91:731-5.
96. Levine R, Berkowitz K. Conservative management and pregnancy outcome in diethylstilbestrol-exposed women with and without gross genital tract abnormalities. Am J Obstet Gynecol 1993;169(5):1125-9.
97. Linn S, Lieberman E, Schoenbaum SC, Monson RR, Stubblefield PG, Ryan KJ. Adverse outcomes of pregnancy in women exposed to diethylstilbestrol in utero. J Reprod Med 1988;33(1):3-7.
98. Mangan CE, Borow L, Burtnett-Rubin MM, Egan V, Giuntoli RL, Mikuta JJ. Pregnancy outcome in 98 women exposed to diethylstilbestrol in utero, their mothers, and unexposed siblings. Obstet Gynecol 1982;59:315-9.
99. Muasher SJ, Garcia JE, Jones HW. Experience with diethylstilbestrol-exposed infertile women in program of in vitro fertilization. Fertil Steril 1984;42(1):20-4.
100. Nunley WC, Kitchin JD. Successful management of incompetent cervix in a primigravida exposed to diethylstilbestrol in utero. Fertil Steril 1979;31:217-9.
Back to Top
|
